跳至主要内容
临床试验/NCT05763173
NCT05763173已完成不适用

The Diagnostic Value of Lung Ultrashort Echo Time MRI for Potential Lung Metastases in Children With Hepatoblastoma

RenJi Hospital1 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
65
试验地点
1
主要终点
UTE-MRI assessment of lung metastases with chest CT as gold standard

研究概览

简要总结

Analyze the diagnostic efficiency (including performance, diameter, and location of nodules) of UTE-MRI in lung metastases of hepatoblastoma with chest CT as gold standard

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
— 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children diagnosed as hepatoblastoma (including treated with neoadjuvant chemotherapy but not surgery)
  • Recent chest CT scan (within 14 days)
  • No MRI contraindications
  • The guardian of the children are willing to undergo the examination after full communication and informed consent

排除标准

  • MRI contraindications (including but not limited to: contrast medium allergy; Claustrophobia;Metal implants;chronic kidney disease≥stage 3 (glomerular filtration rate < 60 mL min-1 (1.73 m2)-1))
  • Patients with hepatoblastoma aged 14 years and above
  • Children after surgery for hepatoblastoma
  • Application of any contrast medium within 24 h before the MRI and/or CT examinations
  • There is a concomitant medical condition (e.g. poorly controlled hypertension, severe diabetes, neurological or psychiatric illness, etc.) or any other condition that would seriously endangers the subject's safety, may confuse the study results, or may interfere with the subject's completion of the study according to the investigator's judgment.

结局指标

主要结局

UTE-MRI assessment of lung metastases with chest CT as gold standard

时间窗: Baseline to 14 days

Analyze the diagnostic efficiency (including performance, diameter, and location of nodules) of UTE-MRI in lung metastases of hepatoblastoma.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验